ADPT · ISSUER CIK 1478320
Adaptive Biotechnologies Corp
Between Aug 1, 2026 and Oct 29, 2026, 7 Adaptive Biotechnologies Corp insiders reported $0.00 of open-market purchases and $29.9M of sales on SEC Form 4.
↗7 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 13 of 17 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$29.9MInsider selling
−$29.9MNet open-market
Oct 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 202619:52 | Oct 29, 2026from Oct 27, 2026 | ADPT | President and COO | S · Sell10b5-1 | $28.00 | −35,643 | 377,802 | -9% | −$998K | ||
| Oct 29, 202619:52 | Oct 29, 2026from Oct 27, 2026 | ADPT | President and COO | M · Exercise10b5-1 | $12.14 | +35,643 | 389,683 | +10% | $433K | ||
| Oct 26, 202618:52 | Oct 26, 2026from Oct 22, 2026 | ADPT | President and COO | S · Sell10b5-1 | $25.18 | −35,643 | 377,802 | -9% | −$897K | ||
| Oct 26, 202618:52 | Oct 26, 2026from Oct 22, 2026 | ADPT | President and COO | M · Exercise10b5-1 | $12.14 | +35,643 | 389,683 | +10% | $433K | ||
| Oct 21, 202618:36 | Oct 21, 2026from Oct 19, 2026 | ADPT | President and COO | S · Sell10b5-1 | $24.66 | −35,643 | 377,802 | -9% | −$879K | ||
| Oct 21, 202618:36 | Oct 21, 2026from Oct 19, 2026 | ADPT | President and COO | M · Exercise10b5-1 | $12.14 | +35,643 | 389,683 | +10% | $433K | ||
| Oct 16, 202619:21 | Oct 16, 2026from Oct 14, 2026 | ADPT | President and COO | S · Sell10b5-1 | $25.18 | −35,643 | 377,802 | -9% | −$897K | ||
| Oct 16, 202619:21 | Oct 16, 2026from Oct 14, 2026 | ADPT | President and COO | M · Exercise10b5-1 | $12.14 | +35,643 | 389,683 | +10% | $433K | ||
| Oct 13, 202619:05 | Oct 13, 2026from Oct 9, 2026 | ADPT | President and COO | S · Sell10b5-1 | $25.81 | −35,643 | 377,802 | -9% | −$920K | ||
| Oct 13, 202619:05 | Oct 13, 2026from Oct 9, 2026 | ADPT | President and COO | M · Exercise10b5-1 | $12.14 | +35,643 | 389,683 | +10% | $433K | ||
| Oct 8, 202618:54 | Oct 8, 2026from Oct 6, 2026 | ADPT | President and COO | S · Sell10b5-1 | $26.60 | −35,643 | 377,802 | -9% | −$948K | ||
| Oct 8, 202618:54 | Oct 8, 2026from Oct 6, 2026 | ADPT | President and COO | M · Exercise10b5-1 | $12.14 | +35,643 | 389,683 | +10% | $433K | ||
| Oct 8, 202618:52 | Oct 6, 2026 | ADPT | Chief Commercial Officer, MRD | S · Sell10b5-1 | $30.00 | −6,444 | 389,350 | -2% | −$193K | ||
| Oct 5, 202620:15 | Oct 5, 2026from Oct 1, 2026 | ADPT | President and COO | S · Sell10b5-1 | $28.46 | −35,643 | 377,802 | -9% | −$1.0M | ||
| Oct 5, 202620:15 | Oct 5, 2026from Oct 1, 2026 | ADPT | President and COO | M · Exercise10b5-1 | $12.14 | +35,643 | 389,683 | +10% | $433K | ||
| Oct 5, 202620:12 | Oct 1, 2026 | ADPT | Chief People Officer | S · Sell10b5-1 | $28.28 | −26,792 | 220,867 | -11% | −$758K | ||
| Oct 5, 202620:12 | Oct 1, 2026 | ADPT | Chief People Officer | M · Exercise10b5-1 | $6.78 | +26,792 | 247,659 | +12% | $182K | ||
| Sep 18, 202620:17 | Sep 16, 2026 | ADPT | Chief People Officer | S · Sell10b5-1 | $28.06 | −115,406 | 220,867 | -34% | −$3.2M | ||
| Sep 18, 202620:17 | Sep 16, 2026 | ADPT | Chief People Officer | M · Exercise10b5-1 | $9.57 | +105,560 | 336,273 | +46% | $1.0M | ||
| Sep 17, 202618:50 | Sep 15, 2026 | ADPT | Chief Commercial Officer, MRD | S · Sell10b5-1 | $27.00 | −1,195 | 395,794 | -0% | −$32K | ||
| Sep 2, 202619:12 | Aug 31, 2026 | ADPT | Director | G · Gift | — | −12,539 | 66,100 | -16% | — | ||
| Aug 28, 202617:50 | Aug 26, 2026 | ADPT | Director | S · Sell | $26.00 | −9,615 | 78,639 | -11% | −$250K | ||
| Aug 20, 202617:55 | Aug 18, 2026 | ADPT | Director | S · Sell | $24.40 | −30,664 | 46,683 | -40% | −$748K | ||
| Aug 20, 202617:55 | Aug 18, 2026 | ADPT | Director | M · Exercise | $6.32 | +15,000 | 77,347 | +24% | $95K | ||
| Aug 19, 202620:15 | Aug 18, 2026from Aug 17, 2026 | ADPT | CEO and Chairman, Director | S · Sell | $24.80 | −600,000 | 2,180,518 | -22% | −$14.9M | ||
| Aug 19, 202620:15 | Aug 18, 2026from Aug 17, 2026 | ADPT | CEO and Chairman, Director | M · Exercise | $6.55 | +600,000 | 2,459,194 | +32% | $3.9M | ||
| Aug 19, 202620:07 | Aug 17, 2026 | ADPT | Director | S · Sell | $25.15 | −124,690 | 130,625 | -49% | −$3.1M | ||
| Aug 19, 202620:07 | Aug 17, 2026 | ADPT | Director | M · Exercise | $6.32 | +15,000 | 255,315 | +6% | $95K | ||
| Aug 12, 202619:33 | Aug 10, 2026 | ADPT | Chief Commercial Officer, MRD | S · Sell10b5-1 | $25.00 | −3,000 | 396,989 | -1% | −$75K | ||
| Aug 3, 202618:26 | Jul 30, 2026 | ADPT | Chief Commercial Officer, MRD | S · Sell10b5-1 | $24.00 | −1,299 | 399,989 | -0% | −$31K |